This site is intended for healthcare professionals
Idiopathic Pulmonary Fibrosis (IPF) Learning Zone
Declaration of sponsorship Boehringer Ingelheim

Key Learning

Declaration of sponsorship Boehringer Ingelheim
Last updated:12th Nov 2020
Published:14th Oct 2020

Living with IPF: Patient perspectives

Introduction

Interstitial lung diseases (ILDs) include over 200 fibroinflammatory diseases that affect the alveolar interstitium of the lung1,2

The most common of these is idiopathic pulmonary fibrosis (IPF) which accounts for between 17–37% of ILDs1.

Register for free exclusive healthcare eLearning resources


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest